CitiGist
  • Home
  • News
  • Sport
  • Politics
  • Gossips
    • Bio
    • Celebrity
  • People
    • Celeb Zone
  • Advertise
CitiGist
  • Home
  • News
  • Sport
  • Politics
  • Gossips
    • Bio
    • Celebrity
  • People
    • Celeb Zone
  • Advertise
Home Biopharmaceuticals

Browsing Tag

Biopharmaceuticals

15 posts
  • Business

Vista Outdoor rejects unsolicited $35-a-share all-cash bid from MNC Capital

Vista Outdoor rejects unsolicited $35-a-share all-cash bid from MNC Capital
Vista Outdoor Inc.’s stock fell slightly early Monday, after the maker of…
  • CitiGist
  • March 4, 2024
View Post
  • Business

Opinion: We’re spending more on leisure and travel. These 11 stocks will soak it up.

Opinion: We’re spending more on leisure and travel. These 11 stocks will soak it up.
Leisure stocks are likely to outperform this year as emboldened consumers kick…
  • CitiGist
  • February 26, 2024
View Post
  • Business

Eli Lilly’s results top estimates as obesity drug gains insurance coverage

Eli Lilly's results top estimates as obesity drug gains insurance coverage
Eli Lilly and Co.’s fourth-quarter sales and profit beat expectations as its…
  • CitiGist
  • February 6, 2024
View Post
  • Business

Novartis to bolster its oncology portfolio with acquisition of MorphoSys

Novartis to bolster its oncology portfolio with acquisition of MorphoSys
Novartis AG on Monday announced it has agreed to buy German biopharmaceutical…
  • CitiGist
  • February 6, 2024
View Post
  • Business

Solo Stove’s stock on track for its largest-ever one-day loss on heels of revenue warning

Solo Stove’s stock on track for its largest-ever one-day loss on heels of revenue warning
Solo Brands Inc.’s stock fell 32% Monday after the maker of Solo…
  • CitiGist
  • January 8, 2024
View Post
  • Business

Omega Therapeutics stock more than doubles on Novo Nordisk obesity drug research pact

Omega Therapeutics stock more than doubles on Novo Nordisk obesity drug research pact
Novo Nordisk has entered research collaboration agreements with Omega Therapeutics Inc. and…
  • CitiGist
  • January 4, 2024
View Post
  • Business

Ionis, AstraZeneca get FDA approval for rare genetic disease treatment

Ionis, AstraZeneca get FDA approval for rare genetic disease treatment
Ionis Pharmaceuticals IONS, +1.61% and AstraZeneca’s AZN, +0.79% Wainua has been approved…
  • CitiGist
  • December 22, 2023
View Post
  • Business

These advisers say markets are expecting unrealistic outcomes. Here are some alternatives.

These advisers say markets are expecting unrealistic outcomes. Here are some alternatives.
Stocks are poised for an upbeat finish to the best month of…
  • CitiGist
  • November 30, 2023
View Post
  • Business

Wuxi XDC Cayman shares surge in Hong Kong debut

Wuxi XDC Cayman shares surge in Hong Kong debut
Wuxi XDC Cayman’s shares rose in their trading debut in Hong Kong…
  • CitiGist
  • November 17, 2023
View Post
  • Business

Stock movers: Snapchat, Theseus Pharmaceuticals, Azenta, Beauty Health, Fisker

Stock movers: Snapchat, Theseus Pharmaceuticals, Azenta, Beauty Health, Fisker
Azenta Inc.‘s stock AZTA, +0.59% rose 7% after the biotech company’s fiscal…
  • CitiGist
  • November 14, 2023
View Post
  • Business

Amgen gets FDA approval for its inflammatory diseases treatment Wezlana

Amgen gets FDA approval for its inflammatory diseases treatment Wezlana
Amgen AMGN, -2.85% has received approval from the U.S. Food and Drug…
  • CitiGist
  • November 1, 2023
View Post
  • Business

PTC Therapeutics stock jumps on royalty deal worth up to $1.5 billion

PTC Therapeutics stock jumps on royalty deal worth up to $1.5 billion
PTC Therapeutics shares PTCT, +12.78% jumped 12% premarket on Thursday after the…
  • CitiGist
  • October 19, 2023
View Post
  • Business

Ardelyx wins long battle for FDA approval of kidney-disease treatment 

Ardelyx wins long battle for FDA approval of kidney-disease treatment 
Ardelyx Inc. ARDX, -0.58% on Tuesday won its long fight for U.S.…
  • CitiGist
  • October 18, 2023
View Post
  • Business

Stock movers: Pfizer, Lululemon, BioNTech, Moderna, Novavax, Manchester United

Stock movers: Pfizer, Lululemon, BioNTech, Moderna, Novavax, Manchester United
Here are some of the biggest moving shares ahead of Monday’s market…
  • CitiGist
  • October 16, 2023
View Post
  • Business

Pfizer stock sinks as pharma giant cuts earnings outlook on weaker COVID demand

Pfizer stock sinks as pharma giant cuts earnings outlook on weaker COVID demand
Shares of Pfizer Inc. and other biotech drug makers fell in the…
  • CitiGist
  • October 14, 2023
View Post
Recent Posts
  • Family Seeks Second Post-Mortem Exam After Designer’s Mysterious Death at Hamptons Yacht Club
  • Red-faced Buckingham Palace inserts a VERY embarrassing falsehood into its ’75 facts about Princess Anne’ for her birthday
  • CA Voters Back Redistricting Body Newsom Wants To Bypass
  • Filing a claim as part of the AT&T $177 million settlement? That could just be the start of your class-action journey.
  • Wrexham confirm record ‘£10m’ signing of former Premier League striker – as Hollywood-owned club continue summer spree
Family Seeks Second Post-Mortem Exam After Designer’s Mysterious Death at Hamptons Yacht Club
  • Crime

Family Seeks Second Post-Mortem Exam After Designer’s Mysterious Death at Hamptons Yacht Club

The family of Irish fashion designer, Martha Nolan-O’Slatarra, found mysteriously dead…
  • CitiGist
  • August 14, 2025
Red-faced Buckingham Palace inserts a VERY embarrassing falsehood into its '75 facts about Princess Anne' for her birthday
  • Entertainment

Red-faced Buckingham Palace inserts a VERY embarrassing falsehood into its ’75 facts about Princess Anne’ for her birthday

Royal watchers might have expected Buckingham Palace to celebrate Princess Anne’s…
  • CitiGist
  • August 14, 2025
Gavin Newsom speaking at a presser.
  • News

CA Voters Back Redistricting Body Newsom Wants To Bypass

California voters overwhelmingly support an independent redistricting commission Gov.…
  • CitiGist
  • August 14, 2025
Filing a claim as part of the AT&T $177 million settlement? That could just be the start of your class-action journey.
  • Business

Filing a claim as part of the AT&T $177 million settlement? That could just be the start of your class-action journey.

A variety of sources can help consumers learn about suits they may…
  • CitiGist
  • August 14, 2025
CitiGist
  • Home
  • News
  • Sport
  • Politics
  • Gossips
  • People
  • Advertise
Designed & Developed by Code Supply Co.